Medical News

RSS

Wisconsin town has highest rate of living wills, lowest cost of care

NPR reports on a town in Wisconsin with the highest rates of living wills in the country.

17 Nov 2009

ChromaDex discloses financial results for third-quarter 2009

ChromaDex Corporation, a leader in phytochemical reference standards and contract research, today announced financial results for the third quarter of 2009. On a reported basis calculated in accordance with U.S. Generally Accepted Accounting Principles (U.S. GAAP), ChromaDex announced a net loss attributable to common stockholders of $0.01 per share for the thirteen week period ended October 3, 2009.

17 Nov 2009

Oncolytics Biotech's REOLYSIN combined with paclitaxel and carboplatin well tolerated for advanced cancers

Oncolytics Biotech Inc. today announced updated results from a Phase I/II U.K. trial (REO 011) of REOLYSIN(R) combined with paclitaxel/carboplatin for patients with advanced cancers in a poster presentation at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference being held in Boston, Massachusetts.

17 Nov 2009

RAE Systems' gamma radiation detector granted U.S. patent

RAE Systems Inc., a leader in delivering innovative sensor solutions to serve energy, hazardous material management, industrial safety, government safety and environmental markets worldwide, was granted U.S. Patent 7,592,603 B2 for a gamma radiation detector that can perform both rate and dose measurements simultaneously.

17 Nov 2009

Liberals push Reid to stand by public option in health bill

Senate Majority Leader Harry Reid is trying to hold together members of his caucus to vote for a government-run public option for health insurance that would allow states to opt-out of the plan — a plan that is getting an icy reception, even among Democrats, Bloomberg reports. Reid's "version … probably won't require employers to cover workers and will be funded through a tax on high-end insurance plans, which would put him at odds with House Democrats.

17 Nov 2009

AIDS advocates ask White House to send money south

WLBT: "The White House Office of National AIDS Policy chose Jackson [Mississipppi] to host an HIV/AIDS town hall meeting Monday night. The community discussion allowed Mississippians to give feedback that will be included in a national strategy to end the HIV/AIDS epidemic. ... Many asked for sex and STD education in the schools, more doctors and transportation funding in rural areas and health insurance" (Anderson, 11/17).

17 Nov 2009

First-quarter fiscal 2010 results announced by Senesco Technologies

Senesco Technologies, Inc. today reported financial results for the three months ended September 30, 2009.

17 Nov 2009

Helicos Genetic Analysis System to be installed at the Leiden Genome Technology Center

Helicos BioSciences Corporation, today announced the sale of a Helicos® Genetic Analysis System to a collaborative Dutch research group led by the Leiden University Medical Center (LUMC), further including the medical centers of Amsterdam (AMC) Groningen (UMCG) and Rotterdam (Erasmus MC) and funded by a grant from NWO, the Netherlands Organization of Scientific Research.

17 Nov 2009

CONMED Linvatec produces the smallest Biocomposite Interference screw for fixation of ACL and PCL grafts

CONMED Corporation's CONMED Linvatec arthroscopy unit today announced the release of new sizes of its Matryx™ Biocomposite Interference Screw. These new screws represent the latest advance in biocomposite material technology that allows CONMED Linvatec to produce the smallest Biocomposite Interference screw available on the market today for primary fixation of ACL and PCL grafts.

17 Nov 2009

Cancer pain drug market to be $3.7 billion in 2018

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, driven by the continued dominance of opioids that include immediate-release morphine and novel fast acting opioid reformulations, the cancer pain drug market will increase from $2.3 billion in 2008 to $3.7 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

17 Nov 2009

Bavarian Nordic awarded a new contract for developing a freeze-dried version of its IMVAMUNE smallpox vaccine

Bavarian Nordic A/S announced today that BARDA (Biomedical Advanced Research and Development Authority) has awarded a new contract to Bavarian Nordic for the development of a freeze-dried version of its IMVAMUNE(R) smallpox vaccine with a total prospective value of USD 40 million.

17 Nov 2009

IMIX Americas launches new TFT-based Slimline DR detectors

IMIX Americas Inc., an innovative provider of high-value digital radiography (DR) systems, has expanded its product line with the addition of a thin detector option. The new TFT-based Slimline detectors join the company’s proprietary IMIXhorizon™ high-resolution CCD-based detectors, resulting in a comprehensive line of affordable, high-quality DR systems that meet a wide variety of imaging needs.

17 Nov 2009

Neuralstem provides financial and business updates for third-quarter 2009

Neuralstem, Inc. today provided a financial and business update for the third quarter ended September 30, 2009.

17 Nov 2009

Non-clinical data from Cytokinetics' smooth muscle contractility program presented

Cytokinetics, Incorporated announced today that three abstracts summarizing non-clinical data regarding its smooth muscle contractility program were presented at the 2009 Scientific Sessions of the American Heart Association in Orlando, Florida.

17 Nov 2009

Atrium Medical presents interim results from its COBEST clinical study at the 2009 VIVA meeting

Atrium Medical Corporation is proud to announce the release of the interim results from the COBEST clinical study. This study is to evaluate the use of bare metal stents vs. balloon expandable covered stents for the treatment of aorto-iliac occlusive disease. Prof. Patrice Mwipatayi of Royal Perth Hospital, Australia, presented interim data on the Covered versus Balloon Expandable Stent Trial known as COBEST at the 2009 VIVA (Vascular InterVentional Advances) meeting in Las Vegas.

17 Nov 2009

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.

17 Nov 2009

YM BioSciences presents preclinical results of its small molecule VDA at the AACR-NCI-EORTC conference

YM BioSciences Inc., a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development, announced that preclinical results for CYT997 were presented today in a poster by Cytopia Limited at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference in Boston, Massachusetts.

17 Nov 2009

Anacor Pharmaceuticals commences patient dosing in AN3365 Phase I clinical study

Anacor Pharmaceuticals today announced that it has dosed the first patient in a Phase I clinical study for AN3365, a novel boron-based, small-molecule drug candidate in development for the treatment of hospital infections caused by Gram-negative bacteria. The study will evaluate the safety, tolerability and pharmacokinetics of AN3365 in healthy volunteers.

17 Nov 2009

China Sky One Medical reports financial results for third-quarter 2009

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company in the People's Republic of China ("PRC"), today announced record financial results for the third quarter of 2009.

17 Nov 2009

American Biotech Labs' ASAP Antibacterial Silver Gel receives FDA 510(k) medical device clearance

American Biotech Labs, LLC (ABL), developer of a new class of products based on the company's patented nano-catalytic SilverSol Technology(R), today announced that the company has obtained clearance by the U.S. Food and Drug Administration (FDA) to market its ASAP Antibacterial Silver Wound Dressing Gel as a prescription 510(k) medical device throughout the United States. Clifton Mining Company is a major shareholder in American Biotech Labs.

17 Nov 2009

Medical News

Wisconsin town has highest rate of living wills, lowest cost of care

ChromaDex discloses financial results for third-quarter 2009

Oncolytics Biotech's REOLYSIN combined with paclitaxel and carboplatin well tolerated for advanced cancers

RAE Systems' gamma radiation detector granted U.S. patent

Liberals push Reid to stand by public option in health bill

AIDS advocates ask White House to send money south

First-quarter fiscal 2010 results announced by Senesco Technologies

Helicos Genetic Analysis System to be installed at the Leiden Genome Technology Center

CONMED Linvatec produces the smallest Biocomposite Interference screw for fixation of ACL and PCL grafts

Cancer pain drug market to be $3.7 billion in 2018

Bavarian Nordic awarded a new contract for developing a freeze-dried version of its IMVAMUNE smallpox vaccine

IMIX Americas launches new TFT-based Slimline DR detectors

Neuralstem provides financial and business updates for third-quarter 2009

Non-clinical data from Cytokinetics' smooth muscle contractility program presented

Atrium Medical presents interim results from its COBEST clinical study at the 2009 VIVA meeting

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

YM BioSciences presents preclinical results of its small molecule VDA at the AACR-NCI-EORTC conference

Anacor Pharmaceuticals commences patient dosing in AN3365 Phase I clinical study

China Sky One Medical reports financial results for third-quarter 2009

American Biotech Labs' ASAP Antibacterial Silver Gel receives FDA 510(k) medical device clearance

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News